Doug Drysdale is the Chief Executive Officer of Cybin. During Doug’s tenure as CEO of Cybin, the company was taken public on the NYSE and now has two clinical-stage programs in development for the treatment of major depressive disorder and generalized anxiety disorder. During Doug’s 35+ years of experience in the healthcare sector, he has built cohesive management teams, recruited board members, created multinational operations, and has raised around $4 billion of both public and private capital. As founding CEO of Alvogen, Doug led the company from inception to around $500mm in revenues, across 35 countries. Previously, Doug was Head of M&A at Actavis Group, leading 15 corporate acquisitions across three continents, between 2004 and 2008. In 2012 Doug was named E&Y Entrepreneur of the Year.